Nitin Jain: Wonderful to celebrate India’s CD19 CAR T approval

Nitin Jain, the Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center, shared on X/Twitter:

“Wonderful to celebrate India’s CD19 CAR-T approval on the sidelines of ASH23 with the ImmunoACT team Rahul Purwar, Hasmukh Jain, Gaurav Narula, Dr. Nirali Shah, and ACTREC-TMC (Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer).

A great advance for patients in India and beyond.”

Source: Nitin Jain/X